Table 3.
In vitro analysis of ALP and calcium content
| Treatment period | Sample code | Calcium concentration (mg/dL) | ALP Activity(U/L) |
|---|---|---|---|
| DAY 7 | Control | 4.1494 ± 0.2422 | 34.0866 ± 0.8901 |
| PRME | 5.1766 ± 0.3177 | 44.3709 ± 1.1960 | |
| Alendronate | 5.3474 ± 0.3503 | 51.2585 ± 1.0190 | |
| DAY 14 | Control | 4.5568 ± 0.4449 | 56.7055 ± 1.5684 |
| PRME | 6.0941 ± 0.3493 | 75.4896 ± 1.2429 | |
| Alendronate | 6.6287 ± 0.4524 | 83.1011 ± 1.6357 |
Values are expressed as mean ± standard deviation (n = 3). Where; PRME Pterospermum rubiginosum methanolic bark extract, mg/dL milligrams per deciliter, U/L Units per litre